Wang YK, Liu YH, Shuang WB. Giant retroperitoneal hemolymphangioma: A case report and review of literature. World J Clin Cases 2024; 12(22): 5258-5262 [DOI: 10.12998/wjcc.v12.i22.5258]
Corresponding Author of This Article
Wei-Bing Shuang, PhD, Chief Physician, Instructor, Department of Urology, The First Hospital of Shanxi Medical University, No. 85 JieFang South Road, Yingze District, Taiyuan 030001, Shanxi Province, China. shuangweibing@126.com
Research Domain of This Article
Oncology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Aug 6, 2024; 12(22): 5258-5262 Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.5258
Giant retroperitoneal hemolymphangioma: A case report and review of literature
Yi-Kai Wang, Ying-Hao Liu, Wei-Bing Shuang
Yi-Kai Wang, Ying-Hao Liu, Wei-Bing Shuang, Department of Urology, The First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
Author contributions: Shuang WB designed the research study; Wang YK and Liu YH performed the research; Wang YK contributed new reagents and analytic tools; Wang YK and Shuang WB analyzed the data and wrote the manuscript; All authors have read and approved the final manuscript.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare no competing interests.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wei-Bing Shuang, PhD, Chief Physician, Instructor, Department of Urology, The First Hospital of Shanxi Medical University, No. 85 JieFang South Road, Yingze District, Taiyuan 030001, Shanxi Province, China. shuangweibing@126.com
Received: April 25, 2024 Revised: May 23, 2024 Accepted: June 11, 2024 Published online: August 6, 2024 Processing time: 68 Days and 7.6 Hours
Abstract
BACKGROUND
Hemolymphangioma is a very rare benign tumor in clinical practice caused by abnormalities of the vasculature. Its clinical features are often atypical, and it is easy to miss and misdiagnose. When the time of nuclear magnetic T1 is significantly reduced, the diagnosis of hemangioma should be considered. Therefore, we report this case in the hope of raising clinicians' awareness of the disease.
CASE SUMMARY
A 37-year-old man presented with a giant retroperitoneal hemolymphangioma. Computed tomography and magnetic resonance imaging indicated the possibility of a large perirenal lymphatic cyst. The postoperative pathological diagnosis is retroperitoneal hemolymphangioma. The patient underwent surgical excision after adequate drainage. The postoperative recovery was smooth and there were no complications. There was no recurrence during half a year of follow-up.
CONCLUSION
This case reiterates that large retroperitoneal cystic masses with significantly shortened nuclear T1 time should be considered hemolymphangioma. Specific clinical basis and experience for the diagnosis and treatment of these diseases is necessary.
Core Tip: The clinical features of hemolymphangioma are often atypical, and it is easy to miss and misdiagnose. When the time of nuclear magnetic T1 is significantly reduced, the diagnosis of hemolymphangioma should be considered. Retroperitoneal hemolymphangiomas are usually very large and puncture drainage can be an early treatment option.
